WUND Healing BioPharmaceuticals, Inc. — Regulation A 1-A
WUND Healing BioPharmaceuticals, Inc. of Las Vegas, NV filed a Regulation A 1-A with the SEC on 2026-06-29. Aggregate offering: $10 (Tier 2). Industry: Other.
Offering
- Filed: 2026-06-29
- Form: 1-A
- Accession: 0001477932-26-004058
- Tier: Tier 2
- Total aggregate offering: $10
- Issuer portion: $10
- Price per security: $10.0000
- Securities offered: Equity (common or preferred stock)
- Underwriter: Benjamin Securities, Inc
- Audit status: Audited
- Auditor: Salberg & Company, P.A.
- Jurisdictions: 3 states/territories
Issuer
- CIK: 0002078607
- Organized in: NV
- Incorporated: 2016
- Address: 8683 W. Sahara Avenue, Las Vegas, NV, 89117
- Phone: 702-800-0030
Financial snapshot (as filed)
- Total assets: $379K
- Cash & equivalents: $160K
- Total liabilities: $1.2M
- Stockholder equity: $-815K
- Net income: $308K
More